We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPE
6376
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$19K ﹤0.01%
122
+103
+542% +$43.1K
MTOR
6377
CALL
DELISTED
MERITOR, Inc.
MTOR
$19K ﹤0.01%
1,000
-6,800
-87% -$143K
BGG
6378
PUT
DELISTED
Briggs & Stratton Corp.
BGG
$19K ﹤0.01%
1,000
-1,200
-55% -$22.7K
ENLK
6379
CALL
DELISTED
EnLink Midstream Partners, LP
ENLK
$19K ﹤0.01%
1,000
-100
-9% -$1.74K
AFSI
6380
CALL
DELISTED
AmTrust Financial Services, Inc.
AFSI
$19K ﹤0.01%
1,300
FIYY
6381
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
$19K ﹤0.01%
+180
New +$18.1K
AES icon
6382
PUT
AES
AES
$10.5B
$18K ﹤0.01%
1,300
-11,400
-90% -$154K
DNTH icon
6383
Dianthus Therapeutics
DNTH
$6.09B
$18K ﹤0.01%
+95
New +$20K
EWA icon
6384
PUT
iShares MSCI Australia ETF
EWA
$1.48B
$18K ﹤0.01%
800
+600
+300% +$13.5K
HALO icon
6385
PUT
Halozyme
HALO
$12.2B
$18K ﹤0.01%
1,000
PRGS icon
6386
CALL
Progress Software
PRGS
$1.76B
$18K ﹤0.01%
+500
New +$19.9K
SPR
6387
CALL
DELISTED
Spirit AeroSystems
SPR
$18K ﹤0.01%
200
-3,800
-95% -$334K
VCTR icon
6388
Victory Capital Holdings
VCTR
$6.65B
$18K ﹤0.01%
1,901
-147
-7% -$1.45K
VST icon
6389
PUT
Vistra
VST
$47.4B
$18K ﹤0.01%
715
DBD
6390
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
$18K ﹤0.01%
4,100
-10,500
-72% -$76.6K
NH
6391
DELISTED
NantHealth, Inc
NH
$18K ﹤0.01%
780
+679
+672% +$25.8K
QES
6392
DELISTED
Quintana Energy Services Inc.
QES
$18K ﹤0.01%
2,491
+1,435
+136% +$11.1K
ARL icon
6393
American Realty Investors
ARL
$248M
$17K ﹤0.01%
975
+824
+546% +$14.3K
BSVN icon
6394
Bank7 Corp
BSVN
$481M
$17K ﹤0.01%
+900
New +$17.2K
CEE
6395
Central and Eastern Europe Fund
CEE
$139M
$17K ﹤0.01%
700
CNVS icon
6396
Cineverse
CNVS
$65.6M
$17K ﹤0.01%
735
EQNR icon
6397
CALL
Equinor
EQNR
$92.4B
$17K ﹤0.01%
+600
New +$15.8K
EXP icon
6398
PUT
Eagle Materials
EXP
$6.57B
$17K ﹤0.01%
200
-2,600
-93% -$252K
FTV icon
6399
PUT
Fortive
FTV
$18.6B
$17K ﹤0.01%
+317
New +$16.3K
IMUX icon
6400
CALL
Immunic
IMUX
$195M
$17K ﹤0.01%
+158
New +$412K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.